HER2
![](https://upload.wikimedia.org/wikipedia/commons/thumb/4/4a/Trastuzumab-HER2_complex_1N8Z.png/250px-Trastuzumab-HER2_complex_1N8Z.png)
![](https://upload.wikimedia.org/wikipedia/commons/thumb/1/11/Pertuzumab-HER2_complex_1S78.png/250px-Pertuzumab-HER2_complex_1S78.png)
HER2(ハーツー)は、
HER2タンパクは
発見 の歴史
[1985
また
機能
[HER2は
HER2タンパクは
遺伝子
[ヒトHER2をコードする
悪性 腫瘍 におけるHER2
[HER2は
またHER2タンパクを
HER検査 の評価 法
[HER2
IHC法 によるHER2検査 の判定 スコア(2018 ASCO/CAPガイドライン)
[![]() |
|
---|---|
0 | |
1+ | 10% |
2+ | 10% |
3+ | 10%を |
FISH法 によるHER2検査 の判定 スコア(2007 ASCO/CAPガイドライン)
[FISHの | |
---|---|
HER2/17cen(CEP17) | |
HER2/17cen(CEP17) | |
HER2/17cen(CEP17) |
HER2蛋白 および遺伝子 の検査 キット
[キット |
||||
---|---|---|---|---|
ダコHercep Test ヒストファインHer2キット ベンタナパスウェイHER2 |
ダコ・ジャパン ニチレイ ロッシュ・ダイアグノステイクス | |||
FISH |
DNA | パスビジョンHER-2 DNA プローベキット ヒストラHER2 FISHキット | アボットジャパン | |
CLEIA | ケミルミADVIA Centaur CP | シーメンス |
CLEA: chemiluminescence enzyme immunoassay [14]
HER2を標的 にした治療
[HER2タンパクを
トラスツズマブ
[トラスツズマブ(ハーセプチン®)はHER2タンパクに
ペルツズマブ
[ペルツズマブは、トラスツズマブと
参考 文献
[- ^ a b Coussens L, Yang-Feng TL, Liao YC, et al. "Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene." Science, Vol.230, No.4730, 1985, p.p. 1132-1139. PMID 2999974
- ^ a b Semba K, Kamata N, Toyoshima K, et al. "A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma." Proceedings of National Academy of Science of United States of America, Vol.82, No.19, 1985, p.p. 6497-6501. PMID 2995967
- ^ King CR, Kraus MH, Saronson SA. "Amplification of a novel v-erbB-related gene in a human mammary carcinoma." Science, Vol.229, No.4717, 1985, p.p. 974-976. PMID 2992089
- ^ Akiyama T, Sudo C, Ogawara H, et al. "The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity." Science, Vol.232, No.4758, 1986, p.p. 1644-1646. PMID 3012781
- ^ Lee KF, Simon H, Chen H, et al. "Requirement for neuregulin receptor erbB2 in neural and cardiac development." Science, Vol.378, No.6555, 1995, p.p. 394-398. PMID 7477377
- ^ Crone SA, Zhao YY, Fan L, et al. "ErbB2 is essential in the prevention of dilated cardiomyopathy." Nature Medicine, Vol.8, No.5, 2002, p.p. 459-465. PMID 11984589
- ^ Ozcelik C, Erdmann B, Pilz B, et al. "Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy." Proceedings of National Academy of Science of United States of America, Vol.99, Bo.13, 2002, p.p. 8880-8885. PMID 12072561
- ^ Crone SA, Negro A, Trumpp A, et al. "Colonic epithelial expression of ErbB2 is required for postnatal maintenance of the enteric nervous system." Neuron, Vol.37, No.1, p.p. 29-40. PMID 12526770
- ^ Graus-Porta D, Beerli RR, Daly JM, Hynes NE. "ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling." EMBO Journal, Vol.16, No.7, 1997, p.p. 1647-1655. PMID 9130710
- ^ Tse C, Gauchez A, Jacot W, Lamy P. HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer Cancer Treatment Reviews 2011
- ^ ERBB2 - Entrez Gene
- ^ a b Slamon DJ, Clark GM, Wong SG, et al. "Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene." Science, Vol.235, No.4785, 1987, p.p. 177-182. PMID 3798106
- ^ American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF; American Society of Clinical Oncology/College of American Pathologists. Arch Pathol Lab Med. 2007;131(1):18-43.
- ^
熊木 伸枝 、梅村 しのぶ「HER2の検索 法 と陽性 の基準 」戸井 雅和 編 「みんなに役立 つ乳癌 の基礎 と臨床 」p372 - ^ Slamon DJ, Leyland-Jones B, Shak S, et al. "Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2." NEJM., Vol.344, No.11, 2001, p.p. 783-792. PMID 11248153